Cerus - 28 Year Stock Price History | CERS
Historical daily share price chart and data for Cerus since 1997 adjusted for splits and dividends. The latest closing stock price for Cerus as of July 18, 2025 is 1.36.
- The all-time high Cerus stock closing price was 80.50 on December 28, 2000.
- The Cerus 52-week high stock price is 2.54, which is 86.8% above the current share price.
- The Cerus 52-week low stock price is 1.12, which is 17.6% below the current share price.
- The average Cerus stock price for the last 52 weeks is 1.68.
| Cerus Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.4964 | 1.5700 | 2.1500 | 1.2200 | 1.3600 | -11.69% |
| 2024 | 1.9104 | 2.1600 | 2.4200 | 1.5200 | 1.5400 | -28.70% |
| 2023 | 2.2750 | 3.7400 | 3.8100 | 1.2500 | 2.1600 | -40.82% |
| 2022 | 4.7679 | 6.9900 | 6.9900 | 3.3800 | 3.6500 | -46.40% |
| 2021 | 6.3033 | 6.9400 | 7.9300 | 4.7900 | 6.8100 | -1.59% |
| 2020 | 5.8744 | 4.2500 | 8.5600 | 2.8700 | 6.9200 | 63.98% |
| 2019 | 5.3073 | 5.3400 | 6.8500 | 3.8400 | 4.2200 | -16.77% |
| 2018 | 5.9496 | 3.5600 | 7.7800 | 3.5600 | 5.0700 | 50.00% |
| 2017 | 3.3151 | 4.3300 | 4.6100 | 2.0200 | 3.3800 | -22.30% |
| 2016 | 5.8151 | 6.2400 | 7.3900 | 4.2200 | 4.3500 | -31.17% |
| 2015 | 5.0900 | 6.5150 | 6.5900 | 3.8600 | 6.3200 | 1.28% |
| 2014 | 4.7555 | 6.4800 | 7.9500 | 3.5000 | 6.2400 | -3.26% |
| 2013 | 5.0364 | 3.1900 | 6.9400 | 2.9500 | 6.4500 | 104.11% |
| 2012 | 3.3740 | 2.8600 | 4.3200 | 2.7600 | 3.1600 | 12.86% |
| 2011 | 2.7593 | 2.4800 | 3.5700 | 1.9800 | 2.8000 | 13.82% |
| 2010 | 2.8919 | 1.8000 | 3.9300 | 1.7800 | 2.4600 | 23.62% |
| 2009 | 1.4225 | 0.8200 | 2.9800 | 0.6200 | 1.9900 | 184.29% |
| 2008 | 4.3830 | 6.5600 | 7.2400 | 0.5800 | 0.7000 | -89.25% |
| 2007 | 6.9439 | 5.6800 | 10.1800 | 5.1300 | 6.5100 | 11.09% |
| 2006 | 7.9437 | 10.0100 | 14.4800 | 5.3100 | 5.8600 | -42.27% |
| 2005 | 5.7492 | 3.1000 | 11.3300 | 3.0500 | 10.1500 | 244.07% |
| 2004 | 2.9397 | 4.5000 | 4.7100 | 1.8500 | 2.9500 | -35.02% |
| 2003 | 7.4840 | 21.7200 | 21.7200 | 3.4000 | 4.5400 | -78.88% |
| 2002 | 33.4150 | 46.7700 | 58.6800 | 11.8700 | 21.5000 | -53.01% |
| 2001 | 55.9457 | 69.7500 | 75.3500 | 33.6250 | 45.7500 | -39.20% |
| 2000 | 49.3274 | 24.8750 | 80.5000 | 24.8750 | 75.2500 | 183.96% |
| 1999 | 23.9072 | 20.5000 | 31.2500 | 15.4375 | 26.5000 | 26.19% |
| 1998 | 16.4559 | 22.0000 | 23.7500 | 12.0000 | 21.0000 | -4.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.262B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |